Guardian Pharmacy Services, Inc.
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 18.68% | 18.53% | 19.54% | 17.42% | 16.86% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 18.68% | 18.53% | 19.54% | 17.42% | 16.86% |
| Cost of Revenue | 18.77% | 18.97% | 19.55% | 17.44% | 17.45% |
| Gross Profit | 18.32% | 16.72% | 19.52% | 17.31% | 14.49% |
| SG&A Expenses | -22.43% | 95.50% | 111.80% | 107.24% | 66.39% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.62% | 30.64% | 32.76% | 30.61% | 25.66% |
| Operating Income | 284.17% | -188.45% | -174.60% | -183.66% | -187.02% |
| Income Before Tax | 171.79% | -472.74% | -295.76% | -311.79% | -311.49% |
| Income Tax Expenses | 10,701.70% | -- | -- | -- | -- |
| Earnings from Continuing Operations | 148.37% | -543.80% | -318.86% | -323.87% | -311.94% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 103.73% | 61.25% | 16.63% | -17.63% | -26.16% |
| Net Income | 139.99% | -11,393.82% | -511.07% | -521.29% | -526.70% |
| EBIT | 284.17% | -188.45% | -174.60% | -183.66% | -187.02% |
| EBITDA | 626.35% | -141.86% | -135.35% | -141.27% | -128.30% |
| EPS Basic | 132.49% | -- | -- | -- | -- |
| Normalized Basic EPS | 162.12% | -819.62% | -- | -- | -- |
| EPS Diluted | 131.78% | -- | -- | -- | -- |
| Normalized Diluted EPS | 161.15% | -826.97% | -- | -- | -- |
| Average Basic Shares Outstanding | 103.01% | 304.42% | -- | -- | -- |
| Average Diluted Shares Outstanding | 106.30% | 308.85% | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -1.00% | -1.18% | -1.22% | -1.35% |